Isao Kamae

Isao Kamae

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan.

A Cost-Effectiveness Analysis for the Combination of Universal Screening at 9-10 Years Old and Reverse Cascade Screening of Relatives for Familial Hypercholesterolemia in Japan.

Journal: Journal of atherosclerosis and thrombosis

Published: February 16, 2025

Switching from Cigarettes to Heated Tobacco Products in Japan-Potential Impact on Health Outcomes and Associated Health Care Costs.

Switching from Cigarettes to Heated Tobacco Products in Japan-Potential Impact on Health Outcomes and Associated Health Care Costs.

Journal: Healthcare (Basel, Switzerland)

Published: August 12, 2024

Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan.

Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan.

Journal: Journal of medical economics

Published: October 11, 2023

Cost-effectiveness of adding a Helicobacter pylori antibody test to the upper gastrointestinal series in gastric cancer screening at the workplace.

Cost-effectiveness of adding a Helicobacter pylori antibody test to the upper gastrointestinal series in gastric cancer screening at the workplace.

Journal: Environmental and occupational health practice

Published: May 25, 2023

A Theory of Diagnostic Testing to Stop the Virus Spreading: Evidence-based Reasoning to Resolve the COVID-19 Crisis by Testing.

A Theory of Diagnostic Testing to Stop the Virus Spreading: Evidence-based Reasoning to Resolve the COVID-19 Crisis by Testing.

Journal: The Keio journal of medicine

Published: February 03, 2022

Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan.

Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan.

Journal: PloS one

Published: December 24, 2020

Health technology assessment in Japan: a work in progress.

Health technology assessment in Japan: a work in progress.

Journal: Journal of medical economics

Published: January 17, 2020

Defining the concept of fair pricing for medicines.

Defining the concept of fair pricing for medicines.

Journal: BMJ (Clinical research ed.)

Published: January 15, 2020

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis.

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis.

Journal: Intestinal research

Published: November 21, 2019

The Development of Health Technology Assessment in Asia: Current Status and Future Trends.

The Development of Health Technology Assessment in Asia: Current Status and Future Trends.

Journal: Value in health regional issues

Published: February 27, 2019

Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment.

Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: October 18, 2017

A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR JAPAN? SIMULATING THE POTENTIAL IMPACT ON THE PRICE OF SIMEPREVIR.

A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR JAPAN? SIMULATING THE POTENTIAL IMPACT ON THE PRICE OF SIMEPREVIR.

Journal: International journal of technology assessment in health care

Published: June 01, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026